Shanghai Fosun Pharmaceutical (Group) Co., Ltd.

Symbol: 2196.HK

HKSE

13.28

HKD

Trhová cena dnes

  • 15.5749

    Pomer P/E

  • 7.2266

    Pomer PEG

  • 63.71B

    MRK Cap

  • 0.04%

    Výnos DIV

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (2196-HK) Finančné výkazy

Na grafe môžete vidieť predvolené čísla v dynamike pre Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (2196.HK). Príjmy spoločnosti zobrazuje priemerná hodnota NaN M, ktorá je NaN % gowth. Priemerný hrubý zisk za celé obdobie je NaN M, čo je NaN %. Priemerný pomer hrubého zisku je NaN %. Rast čistého zisku za minuloročné výsledky spoločnosti je NaN %, ktorý sa rovná NaN % % v priemere za celú históriu spoločnosti.,

Súvaha

Keď sa ponoríme do fiškálnej trajektórie spoločnosti Shanghai Fosun Pharmaceutical (Group) Co., Ltd., pozorujeme priemerný rast aktív. Je zaujímavé, že táto miera predstavuje , čo odráža maximá aj minimá spoločnosti. V porovnaní medzi štvrťrokmi sa tento údaj upraví na . Pohľad späť za minulý rok odhaľuje celkovú zmenu aktív o NaN. Hodnota akcionárov, vyjadrená celkovým vlastným imaním akcionárov, sa oceňuje na NaN v mene vykazovania. Medziročná zmena tohto aspektu je NaN%.

common:word.in-mln

USD
Growth
TTM20232022202120202019201820172016201520142013201220112010200920082007200620052004200320022001200019991998199719961995

balance-sheet.row.cash-and-short-term-investments

015582.117169.814549.2
11931.9
9989.9
9162.6
7468.2
6044.5
4062.4
3729.5
3111.6
5197.4
3125.9
3562.3
1308.5
1005.7
1079.6
991.3
752.9
688.1
1242.6
629.4
373.1
343.4
170
329.8
25.3
6.6
7.2

balance-sheet.row.short-term-investments

01888.5928.54241.1
1970.1
456.7
616.1
219.3
48.5
33.8
33.8
44.2
224.8
231.3
218.8
11.7
0.1
5.8
2.1
0
5.2
0.2
285.3
0.9
0
0
0
0
0
0

balance-sheet.row.net-receivables

09967.910797.89517.7
7256.7
5873.4
5255.7
4522.5
2976.9
2518.7
3318.7
2256.4
1906.4
1797.3
1426.6
925.2
940.2
732.1
811
673.6
618.3
536.6
406.4
545.2
37.5
58.4
31.4
9.1
5.1
26.3

balance-sheet.row.inventory

07537.86882.45472.3
5162.8
3940.5
3287.4
2750.5
1670.7
1648.8
1604.6
1614.3
1273.4
1123.9
934.4
598
530.5
494.8
607.6
532
472.8
305.1
355.3
120.5
82.8
85
52.3
49.6
18
12.5

balance-sheet.row.other-current-assets

0704.8429.1885.4
733.4
599.5
296
315.3
72.1
95.5
11.2
4.2
4.3
1.9
14.3
475.2
-59.2
210.6
6.5
3.3
0.5
19
16.1
6
207.7
117
96.6
132.7
77
57.4

balance-sheet.row.total-current-assets

033792.635279.230424.6
25084.8
20403.4
18001.7
15056.5
10764.3
8325.4
8664
6986.5
8381.5
6049.1
5937.7
3306.9
2417.3
2517.1
2416.4
1961.9
1779.7
2103.4
1407.2
1044.9
671.4
430.5
510.1
216.7
106.7
103.4

balance-sheet.row.property-plant-equipment-net

022239.416028.113283.9
13002.7
11085.1
9123.1
8315.9
6304.7
5764.9
5681.4
4907.5
3479.7
2627.3
1695.7
1258.8
1145.3
1139.1
1274.4
1240.6
1054
777.2
570.5
349.4
260.6
175.5
74.4
41.6
4.4
3.3

balance-sheet.row.goodwill

01085210337.19400
8677.2
9014
8853.9
8464.3
3473.1
3303.4
3255
2976
1661.8
1585.1
296.4
51.1
51.1
51.1
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.intangible-assets

017378.115925.313433.2
11498.6
10966.2
9192.1
8274.5
3650.6
3245.8
2911.9
2639.4
1782.3
1705.1
533.9
209
200.1
208.4
210.3
197.5
179
114.6
97.9
39.3
48
20.7
0.9
0.5
0
0

balance-sheet.row.goodwill-and-intangible-assets

028230.126262.422833.1
20175.9
19980.2
18046
16738.8
7123.7
6549.2
6166.9
5615.5
3444
3290.2
830.3
260.1
251.2
259.6
210.3
197.5
179
114.6
97.9
39.3
48
20.7
0.9
0.5
0
0

balance-sheet.row.long-term-investments

023123.824620.519679
21801.2
22564
23443.5
20904.5
18801.5
17200.5
14371.1
11560.7
9822.5
10011.5
7960.7
6652.3
3683.8
3465.1
2704.8
0
2108.4
1187.1
741.6
760.6
570.3
219.3
46.1
1.7
0
0

balance-sheet.row.tax-assets

0624.5442.6265.6
244.9
196.1
173.1
144.5
129.6
102.5
101.2
88.1
31.5
16.7
18.4
11.4
12.9
11.8
5.6
0
20.1
36.5
322.4
15.5
-555.5
-211.5
10.6
10.3
0
0

balance-sheet.row.other-non-current-assets

05459.34531.26807.4
3376.5
1890.9
1763.9
810.8
644
259.3
351.6
316.9
347.9
295.9
377.5
37.6
28.5
42.3
22.3
2268.7
29.4
0
0
-2.4
576.3
223.8
4.9
16.3
0.2
0

balance-sheet.row.total-non-current-assets

07967771884.762869.2
58601.2
55716.3
52549.6
46914.5
33003.5
29876.3
26672.3
22488.6
17125.6
16241.7
10882.5
8220.2
5121.6
4917.9
4217.5
3706.8
3390.8
2115.5
1732.4
1162.4
899.7
427.8
137
70.4
4.6
3.3

balance-sheet.row.other-assets

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-assets

0113469.6107163.993293.8
83686
76119.6
70551.4
61971
43767.8
38201.7
35336.3
29475.2
25507.1
22290.8
16820.1
11527.1
7538.9
7435
6633.9
5668.7
5170.5
4218.8
3139.6
2207.3
1571.1
858.2
647.1
287.1
111.3
106.7

balance-sheet.row.account-payables

06159.662845063.7
3289
2397.3
2333.3
1781.9
1149.4
1048.6
905
1136.4
903.7
939.9
827.3
491.3
398
357.8
530.9
560.3
484
339.3
326.3
89.5
70.5
63.6
36.9
50.8
10.8
5.7

balance-sheet.row.short-term-debt

019555.117402.914547.6
14911.8
8920.5
10536.8
10478.2
5650.4
7334.2
3950.7
1424.2
875.3
2187.1
1830.4
1583
502.5
1556.4
1465.2
786.3
682
466.3
772.3
627.5
129.7
39.6
0
22.5
29.5
21

balance-sheet.row.tax-payables

0537929.8727.5
564.7
759.6
478.9
480.1
478.2
503.8
342.9
288.9
162
111.7
247.4
48.9
49.5
73.7
42.1
27.8
38
62.6
61.3
9.5
16.2
8
12.1
10.4
0
-0.1

balance-sheet.row.long-term-debt-total

015554.512844.99697.4
9103
12987.1
12670.1
9814.9
5571
3571.5
3856.7
4199.7
4280.2
3915.1
2758.3
1284.5
1180.5
746.8
545.1
981.2
752.8
1026.9
45.8
25.2
25.2
13.8
30.1
0.5
0.4
14.3

Deferred Revenue Non Current

0639.4632.4512.8
482.2
417.3
363.5
397.1
346.7
169.3
139.6
404.5
627.6
374.2
57.8
64.9
65.2
70.1
-449
-877.5
5.1
5.9
-38.8
0
0
0
0
0
0
0

balance-sheet.row.deferred-tax-liabilities-non-current

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.other-current-liab

0125.29611.21528.6
54.6
249
4574.3
604.6
944.9
352.8
1337.1
309.5
729.9
221.9
110.6
67.6
541.3
44.1
18.8
40.1
33.6
34.1
32
27
16.4
9.2
37.3
0.6
22.7
34.1

balance-sheet.row.total-non-current-liabilities

023095.819756.915608.3
12829.4
19481.7
19035.4
15629.1
8408.9
6592.9
6696
6532.6
6309.3
5928.3
3723.4
2076.8
1337.8
900.5
642.4
1087.7
762.7
1035.3
53.9
25.2
27.9
13.8
42.1
0.5
0.4
14.8

balance-sheet.row.other-liabilities

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.capital-lease-obligations

02049.6745648.4
627.3
410.2
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-liab

056853.35305544918.2
37701.7
36915.4
36958.6
32229.6
18517.5
17532.1
16233.3
11810.7
10202.5
10920
7426.9
4575.1
3093
3118.6
2985.3
2793.7
2356.7
2201.9
1466.2
884.7
352.6
201.1
116.4
154.5
79.3
81.1

balance-sheet.row.preferred-stock

01300.11198.41265.8
933.6
468
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.common-stock

02672.42672.22562.9
2562.9
2562.9
2563.1
2495.1
2414.5
2314.1
2311.6
2240.5
2240.5
1904.4
1904.4
1237.8
1237.8
1237.8
952.1
832
826.5
381.9
381.9
293.8
293.8
226.1
150.7
58.8
20
20

balance-sheet.row.retained-earnings

024542.523216.921039.6
17505
15125.7
12771.5
11111.6
8993.8
6937
5457
7112.7
5703
4483.5
3717.7
3258.2
1184.8
715.1
262.9
349.3
411.3
372.5
182.1
143.4
108.6
114.4
46.8
27.5
6.2
2.9

balance-sheet.row.accumulated-other-comprehensive-income-loss

0-1300.1-1198.4-1265.8
-933.6
-468
-4436.3
-4000.5
-3047.9
-2592.5
-2164.5
-1671.5
-1213.5
-1061.4
-871.5
-654.1
-544.9
-478
0
-9
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.other-total-stockholders-equity

018469.918693.415589.5
16927.7
14199.5
17079.5
15720.6
13829.8
11523
11070.7
7650.6
6828.8
4445.4
3672.4
2634.7
2131.2
2397.4
1875.2
1218.6
1066.4
945.8
845.5
826.8
743.2
264.1
321.7
14.4
5.7
2.7

balance-sheet.row.total-stockholders-equity

045684.844582.539191.9
36995.5
31888.1
27977.7
25326.9
22190.2
18181.6
16674.8
15332.2
13558.8
9771.9
8423
6476.5
4008.9
3872.3
3090.2
2390.9
2304.1
1700.2
1409.5
1264
1145.5
604.5
519.1
100.7
32
25.6

balance-sheet.row.total-liabilities-and-stockholders-equity

0113469.6107163.993293.8
83686
76119.6
70551.4
61971
43767.8
38201.7
35336.3
29475.2
25507.1
22290.8
16820.1
11527.1
7538.9
7435
6633.9
5668.7
5170.5
4218.8
3139.6
2207.3
1571.1
858.2
647.1
287.1
111.3
106.7

balance-sheet.row.minority-interest

010931.59526.59183.6
8988.7
7316.1
5615
4414.6
3060.1
2488.1
2428.2
2332.3
1745.9
1599
970.2
475.5
437.1
444.1
558.3
484.2
509.7
316.7
263.9
58.7
73
52.6
11.6
32
0
0

balance-sheet.row.total-equity

056616.354108.948375.6
45984.3
39204.2
33592.7
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.total-liabilities-and-total-equity

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

Total Investments

025012.325549.123920.1
23771.3
23020.6
24059.6
21123.8
18850
17234.2
14404.9
11604.9
10047.3
10242.8
8179.4
6664
3683.9
3471
2706.9
2227.2
2113.6
1187.3
1026.9
760.6
570.3
219.3
46.1
1.7
0
0

balance-sheet.row.total-debt

035109.630247.724245
24014.8
21907.6
23206.9
20293.1
11221.3
10905.7
7807.4
5623.9
5155.5
6102.1
4588.7
2867.5
1683
2303.2
2010.3
1767.5
1434.8
1493.2
818.1
652.6
154.9
39.6
30.1
22.5
29.5
35.4

balance-sheet.row.net-debt

02141614006.413936.9
14053
12374.4
14660.4
13044.2
5225.3
6877.1
4111.7
2556.5
183
3207.6
1245.2
1570.8
677.3
1229.4
1021.1
1014.6
752
250.8
474
280.4
-188.5
-130.4
-299.7
-2.8
22.9
28.2

Výkaz peňažných tokov

Finančné prostredie spoločnosti Shanghai Fosun Pharmaceutical (Group) Co., Ltd. zaznamenalo za posledné obdobie pozoruhodnú zmenu voľného peňažného toku, ktorý vykazuje posun NaN. Spoločnosť nedávno rozšírila svoje základné imanie vydaním NaN, čo v porovnaní s predchádzajúcim rokom znamená rozdiel NaN. Výsledkom investičnej činnosti spoločnosti bolo čisté použitie hotovosti vo výške NaN v mene vykazovania. V porovnaní s predchádzajúcim rokom ide o posun o NaN. V tom istom období spoločnosť zaznamenala NaN, NaN a NaN, ktoré sú významné pre pochopenie investičných a splátkových stratégií spoločnosti. Finančné aktivity spoločnosti viedli k čistému použitiu hotovosti vo výške NaN, pričom medziročný rozdiel predstavoval NaN. Okrem toho spoločnosť vyčlenila NaN na výplatu dividend svojim akcionárom. Zároveň uskutočnila ďalšie finančné manévre, označované ako NaN, ktoré tiež výrazne ovplyvnili jej peňažný tok v tomto období. Tieto zložky spolu vytvárajú komplexný obraz o finančnej situácii spoločnosti a strategickom prístupe k riadeniu peňažných tokov.

common:word.in-mln

USD
Growth
TTM20232022202120202019201820172016201520142013201220112010200920082007200620052004200320022001200019991998

cash-flows.row.net-income

02895.13947.54987.4
3940
3743.5
3019.9
3585.3
3221.3
2870.7
2369.8
2399.9
1839.3
1384.8
1000.3
2564.3
760.9
690.2
292.8
237.9
282.1
298.2
161.7
141.1
135.8
94.4
64.9

cash-flows.row.depreciation-and-amortization

02965.22335.91834.4
1666.2
1472.1
1320.1
938.6
732.9
649.3
558.4
415.5
286.2
209.9
152.7
134.7
132.5
136.5
132.1
116.7
91.1
56.1
37.6
28.6
28.1
20.1
9.3

cash-flows.row.deferred-income-tax

0-2723.50-4038.6
-2605.1
-2733
-1876.1
-2322.1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.stock-based-compensation

035.954.564.3
55.2
109.1
72.3
10.4
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.change-in-working-capital

0-1081.2-1387.9259.7
-1401.4
-494.6
-535.1
-212.7
-288.1
-101.8
-555.3
-44.5
-28.2
-88.6
11
599.1
13.6
-133.7
-5.4
-107
789.2
23.2
-35
-45.2
0.8
-78
-10.8

cash-flows.row.account-receivables

01605.1-2076.6-1795
-1559.9
-863.3
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.inventory

0-333.9-1430.1-464.7
-1253.4
-505.2
-564.7
-491.1
-65.4
-88.3
-105
-149.6
-155.1
-99.8
-66.2
-70.1
-27.6
109.6
-42.7
-67
-27
56
-11.2
-37.5
12.4
-14.4
-4.9

cash-flows.row.account-payables

0-1605.12076.61795
1559.9
863.3
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.other-working-capital

0-2352.442.2724.5
-148
10.6
29.6
278.4
-222.7
-13.4
-450.3
105.1
126.9
11.2
77.2
669.2
41.2
-243.3
37.2
-40
816.2
-32.8
-23.8
-7.7
-11.6
-63.6
-5.9

cash-flows.row.other-non-cash-items

01322.7-732.4841.5
924.9
1125.3
949
580.8
-1556.1
-1797.2
-1172.7
-1759.4
-1431.8
-1189.5
-960.6
-3036.2
-673.9
-561.5
-234.6
-59.3
-957.3
-227.3
-61.8
-56.3
-26.3
1.7
3.2

cash-flows.row.net-cash-provided-by-operating-activities

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.investments-in-property-plant-an-equipment

0-5336.7-5888.8-4972.6
-4437.1
-3962.1
-3174.9
-2170.6
-1922
-1235.5
-1119.4
-1040.1
-1160.6
-796.8
-339.2
-348.1
-210.6
-209.7
-266.6
-222.6
-205
-264.1
-139.5
-141.5
-126.6
-78
-52.2

cash-flows.row.acquisitions-net

0-923.7-487.6381.4
-140.3
-818.8
-622.6
-7822.6
-249.4
109.9
-1145.7
-2225.2
30.8
12.7
2.1
-2.6
22.8
9.3
18.2
279.9
11.6
25.5
4.9
10.8
17.6
1
0

cash-flows.row.purchases-of-investments

0-943-1501.3-1424.6
-1070.1
-517.9
-2133.4
-2525.7
-1395.7
-2955.3
-1943.2
-364.1
-759.1
-1500.3
-1190.2
-770.2
-563.2
-543.7
-399.3
-349
-665.1
-134.9
-475.3
-317.8
-345.5
-253.5
-46

cash-flows.row.sales-maturities-of-investments

02809.34649.52168.3
2037.2
4916.2
1243.4
1550.6
1492.6
2127
1515.9
1540.7
1484.7
615.5
1348
755.5
822.8
632.3
329.6
76.6
45.4
535.7
254.8
243.5
30.2
43.4
0.4

cash-flows.row.other-investing-activites

0574.8-835.9-9.5
-1095.8
210.6
-557.4
464.2
-372.6
83.9
214.2
285.2
-574.4
-97.6
-85
-32.5
-15.6
58
-17
-222.6
33.9
-0.2
204.6
-282
-19.3
48.2
-2

cash-flows.row.net-cash-used-for-investing-activites

0-3819.3-4064-3857
-4706.2
-172
-5244.9
-10504.1
-2447.1
-1869.9
-2478.3
-1803.5
-978.6
-1766.5
-264.3
-397.8
56.1
-53.7
-335.1
-437.7
-779.2
162.1
-150.5
-487.1
-443.6
-238.9
-99.8

cash-flows.row.debt-repayment

0-21146.2-26280.1-27391.9
-15707.8
-13942.1
-9995.1
-9085.3
-9956.1
-7239.7
-2559.5
-2417.6
-3795.9
-4042.2
-2081.7
-1071.9
-1410.2
-1753.9
-1221
-817.9
-727.4
-665.6
-1613.8
-716.1
-311.2
-62.8
-52.4

cash-flows.row.common-stock-issued

0000
0
0
4851.4
3017.6
2728.5
116.1
1466.1
30.5
3151.1
0
637.8
18.9
16.1
17.2
0
0
9
951.5
8.4
6.7
437.6
0
372.4

cash-flows.row.common-stock-repurchased

0000
0
0
0
14821.2
7694.5
8990.2
4017.4
2105.1
-17.8
0
3083.4
1703.6
1286
2100.3
0
0
873.7
-589.4
1691
1200.8
-48.5
0
-342.4

cash-flows.row.dividends-paid

0-2455.2-2374.4-1914
-1834.6
-1864.4
-1775.5
-1433.5
-1193.5
-1109.3
-962.7
-804.5
-500.9
-437.3
-297.4
-268.6
-257.9
-237.6
-371.9
-200
-149.2
-94.9
-89.8
-78.2
-14.1
-13.4
-9.7

cash-flows.row.other-financing-activites

022265.13308328474.6
19009.5
13870.5
10056.8
2588.7
2172.7
-206.6
-98.3
154.3
3231.9
5392.5
480.3
18.9
16.1
17.2
1963.6
1165.7
8.5
984.4
24.1
41
402.5
117.1
369.8

cash-flows.row.net-cash-used-provided-by-financing-activities

0-1336.24428.5-831.3
1467.1
-1936
3137.5
9908.6
1446
550.7
1863.1
-932.1
2068.4
913
1822.5
401
-349.9
143.1
370.7
147.8
14.6
586.1
19.9
454.2
466.3
41
337.7

cash-flows.row.effect-of-forex-changes-on-cash

073.6128.3-134.7
-300.2
-5.1
-18
-172.5
80.5
36.6
8.9
-31.4
-12
-6
-3.8
-0.7
-4.6
-4.8
-1.2
-0.4
0
-0.1
0
0
0.1
0
0

cash-flows.row.net-change-in-cash

0-1667.74710.3-874.2
-959.5
1109.4
824.7
1812.3
1189.4
338.4
593.9
-1755.3
1743.4
-542.9
1757.7
264.3
-65.4
216.1
219.3
-102
-559.5
898.3
-28.2
35.3
161.2
-159.7
304.5

cash-flows.row.cash-at-end-of-period

09502.411170.16450.7
7324.9
8284.4
7175
6350.3
4538
3348.6
3010.2
2416.3
4171.6
2428.2
2971.1
1213.4
949.1
1014.4
800.2
580.9
682.9
1242.4
344.1
372.3
343.4
170
329.8

cash-flows.row.cash-at-beginning-of-period

011170.16459.77324.9
8284.4
7175
6350.3
4538
3348.6
3010.2
2416.3
4171.6
2428.2
2971.1
1213.4
949.1
1014.4
798.4
580.9
682.9
1242.4
344.1
372.3
337
182.2
329.8
25.3

cash-flows.row.operating-cash-flow

03414.24217.63948.7
2579.8
3222.4
2950.1
2580.2
2110
1621
1200.2
1011.6
665.5
316.6
203.4
261.9
233
131.5
184.9
188.3
205.1
150.1
102.5
68.2
138.4
38.2
66.6

cash-flows.row.capital-expenditure

0-5336.7-5888.8-4972.6
-4437.1
-3962.1
-3174.9
-2170.6
-1922
-1235.5
-1119.4
-1040.1
-1160.6
-796.8
-339.2
-348.1
-210.6
-209.7
-266.6
-222.6
-205
-264.1
-139.5
-141.5
-126.6
-78
-52.2

cash-flows.row.free-cash-flow

0-1922.5-1671.3-1023.8
-1857.3
-739.6
-224.8
409.6
188.1
385.5
80.8
-28.4
-495.1
-480.2
-135.8
-86.2
22.4
-78.2
-81.7
-34.3
0.1
-113.9
-37
-73.4
11.8
-39.8
14.3

Riadok výkazu ziskov a strát

Príjmy Shanghai Fosun Pharmaceutical (Group) Co., Ltd. zaznamenali v porovnaní s predchádzajúcim obdobím zmenu o NaN%. Hrubý zisk spoločnosti 2196.HK sa vykazuje vo výške NaN. Prevádzkové náklady spoločnosti sú NaN, ktoré vykazujú zmenu o NaN% oproti minulému roku. Náklady na odpisy sú NaN, čo predstavuje NaN% zmenu oproti poslednému účtovnému obdobiu. Prevádzkové náklady sa vykazujú vo výške NaN, ktorá vykazuje NaN% medziročnú zmenu. Výdavky na predaj a marketing predstavujú NaN, čo je NaN% zmena oproti predchádzajúcemu roku. EBITDA na základe posledných čísel je NaN, čo predstavuje NaN% medziročný nárast. Prevádzkový zisk je NaN, ktorý vykazuje NaN% zmenu v porovnaní s predchádzajúcim rokom. Zmena čistého príjmu je NaN%. Čistý príjem za posledný rok bol NaN.

common:word.in-mln

USD
Growth
TTM20232022202120202019201820172016201520142013201220112010200920082007200620052004200320022001200019991998199719961995

income-statement-row.row.total-revenue

041399.543951.539005.1
30307
28585.2
24918.3
18533.6
14628.8
12608.6
12025.5
9996.4
7340.8
6485.5
4555.4
3872.3
3773.2
3693.3
3102
2988.5
2425.4
2154.6
1031.7
727.8
579.5
442.5
340.4
190.3
92.7
64.7

income-statement-row.row.cost-of-revenue

021595.323169.720228.3
13431.2
11543.4
10365.3
7609
6718.4
6308
6718.6
5543.4
4126.8
3991.1
2984.6
2610.7
2711.9
2693.8
2282.2
2076
1651.9
1564
668.1
448.9
307.6
248.4
209.3
116.5
65.3
50.1

income-statement-row.row.gross-profit

019804.220781.918776.8
16875.8
17041.7
14553
10924.6
7910.5
6300.6
5307
4453
3214
2494.4
1570.9
1261.6
1061.4
999.5
819.8
912.5
773.6
590.5
363.6
279
271.9
194
131.1
73.9
27.3
14.5

income-statement-row.row.gross-profit-ratio

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.research-development

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-general-administrative

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-expenses

0-17.92683.72276.4
1841.5
1666
44.1
-13.2
181.9
78.3
324.6
97.9
89.9
158.8
62.1
56
30.9
21.9
60.5
96.5
52.8
42.7
18.1
12.3
18.9
10.9
8
10
-0.3
0.5

income-statement-row.row.operating-expenses

018240.91714516055.8
14045.6
14425.7
12185.7
8621
6168.5
4827.1
4114.5
3339.1
2620.4
2149
1394.5
1098.2
939.7
834.5
794.6
829.5
658.2
549.4
304.1
206.9
172.3
102.3
62.6
31.6
14.3
4.9

income-statement-row.row.cost-and-expenses

039836.240314.736284.1
27476.8
25969.1
22551
16230
12886.8
11135.2
10833.1
8882.5
6747.2
6140.2
4379.1
3708.8
3651.6
3528.3
3076.7
2905.5
2310.1
2113.4
972.2
655.7
480
350.7
271.9
148.1
79.6
55

income-statement-row.row.interest-income

0363.6282.6233.7
199.6
186.6
145.7
79.2
80.9
56.2
69.8
63.8
29.7
51.6
19.6
14.5
17.9
12.5
13.8
17.5
13.7
8.7
2.9
13.7
8.1
0
0
0
0
0

income-statement-row.row.interest-expense

01324.8963.8822.5
881
1074.7
929.7
577.5
488.2
470
415
350.5
370.6
314
162.4
132.4
149.6
130.6
83.3
72
37
45.9
36.2
23.7
9.8
-6.1
-3.3
3.1
3
1.5

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.total-other-income-expensenet

0-42.9-3722.2-259.9
-43.3
-1887.5
1212.3
1758.1
1829.5
1898.4
1525.6
1792.3
1529.5
1381.3
1025.6
3101.2
714
591.4
249.1
124.7
159.4
282.5
104.1
76.8
42.6
12.8
5.2
-3.1
-3.1
-1.4

income-statement-row.row.ebitda-ratio-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-operating-expenses

0-17.92683.72276.4
1841.5
1666
44.1
-13.2
181.9
78.3
324.6
97.9
89.9
158.8
62.1
56
30.9
21.9
60.5
96.5
52.8
42.7
18.1
12.3
18.9
10.9
8
10
-0.3
0.5

income-statement-row.row.total-operating-expenses

0-42.9-3722.2-259.9
-43.3
-1887.5
1212.3
1758.1
1829.5
1898.4
1525.6
1792.3
1529.5
1381.3
1025.6
3101.2
714
591.4
249.1
124.7
159.4
282.5
104.1
76.8
42.6
12.8
5.2
-3.1
-3.1
-1.4

income-statement-row.row.interest-expense

01324.8963.8822.5
881
1074.7
929.7
577.5
488.2
470
415
350.5
370.6
314
162.4
132.4
149.6
130.6
83.3
72
37
45.9
36.2
23.7
9.8
-6.1
-3.3
3.1
3
1.5

income-statement-row.row.depreciation-and-amortization

02965.22335.92986.4
2171.8
1472.1
1320.1
938.6
732.9
649.3
558.4
415.5
286.2
209.9
152.7
134.7
132.5
136.5
132.1
116.7
91.1
56.1
37.6
28.6
28.1
20.1
9.3
-7
3.3
1

income-statement-row.row.ebitda-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.operating-income

03307.58296.66313.7
4721.1
6413.2
3535.5
4074.9
3399.4
3297.2
2394.3
2818.8
2036
1580.5
1140.5
3212
807.6
736.7
347.1
234.5
298.2
329.4
168.5
144.1
141.9
106.3
77.3
49.3
9.8
8.7

income-statement-row.row.income-before-tax

03264.64574.46053.8
4677.8
4525.8
3579.6
4061.7
3571.5
3371.8
2718.1
2906.3
2123
1726.7
1202
3264.7
835.7
756.4
341
269.3
312.9
347.8
175.1
152.7
151.4
110.9
79.5
49.3
9.7
8.7

income-statement-row.row.income-tax-expense

0369.5626.91066.4
737.9
782.2
559.7
476.5
350.2
501.2
348.2
506.3
283.8
341.8
201.6
700.4
74.7
66.2
48.2
31.4
30.8
49.6
13.6
11.6
15.7
16.5
12.9
9.1
3.4
2.7

income-statement-row.row.net-income

02386.33730.84728.7
3662.8
3321.6
2707.9
3124.5
2805.8
2460.1
2112.9
2027.1
1563.9
1165.6
863.7
2498.2
690.9
625.8
259.2
159
215.3
263.6
147.2
135.5
128.5
92.2
63.7
36
6.4
6

Často kladené otázky

Čo je Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (2196.HK) celkové aktíva?

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (2196.HK) celkové aktíva sú 113469604813.000.

Aký je ročný obrat podniku?

Ročné príjmy sú N/A.

Aké je ziskové rozpätie podniku?

Zisková marža firmy je 0.475.

Aký je voľný peňažný tok podniku?

Voľný peňažný tok je -0.539.

Aká je čistá zisková marža podniku?

Čistá zisková marža je 0.049.

Aké sú celkové výnosy podniku?

Celkové príjmy sú 0.071.

Aká je Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (2196.HK) čistý zisk (čistý príjem)?

Čistý zisk (čistý príjem) je 2386265813.000.

Aký je celkový dlh firmy?

Celkový dlh je 35109563838.000.

Aké je číslo prevádzkových nákladov?

Prevádzkové výdavky sú 18240906770.000.

Aký je údaj o hotovosti spoločnosti?

Peňažné prostriedky podniku sú 0.000.